Search Results

There are 135183 results for: content related to: Monoclonal Antibodies

  1. ANTIBODIES AND DERIVATIVES

    Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs

    Rodney J. Y. Ho, Milo Gibaldi, Pages: 139–210, 2013

    Published Online : 25 OCT 2013, DOI: 10.1002/9781118660485.ch9

  2. Development of antibody-based therapeutics for oncology indications

    Drug Development Research

    Volume 67, Issue 9, September 2006, Pages: 699–728, Li Yan and Zhenping Zhu

    Version of Record online : 11 DEC 2006, DOI: 10.1002/ddr.20146

  3. Pharmacokinetic Drug-Drug Interaction Potentials for Therapeutic Monoclonal Antibodies: Reality Check

    The Journal of Clinical Pharmacology

    Volume 47, Issue 9, September 2007, Pages: 1104–1118, Kathleen Seitz and Hon Ghui Zhou

    Version of Record online : 23 APR 2013, DOI: 10.1177/0091270007306958

  4. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 794–812, Zephania W. Kwong Glover, Lynn Gennaro, Sandeep Yadav, Barthélemy Demeule, Pin Yee Wong and Alavattam Sreedhara

    Version of Record online : 5 DEC 2012, DOI: 10.1002/jps.23403

  5. The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 3, March 2015, Pages: 930–941, Rinpei Niwa and Mitsuo Satoh

    Version of Record online : 12 JAN 2015, DOI: 10.1002/jps.24316

  6. Anatomy of the antigenic structure of a large memberane autoantigen, the muscle-type nicotinic acetylcholine receptor

    Immunological Reviews

    Volume 163, Issue 1, June 1998, Pages: 89–120, Socrates J. Tzartos, Tom Barkas, M. Thong Cung, Avgi Mamalaki, Michel Marraud, Piotr Orlewski, Danai Papanastasiou, Constantinos Sakarellos, Maria Sakarellos-Daitsiotis, Panayota Tsantili and Vassilios Tsikaris

    Version of Record online : 28 APR 2006, DOI: 10.1111/j.1600-065X.1998.tb01190.x

  7. Antibody-Mediated Drug Delivery Systems for Breast Cancer Therapeutics

    Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

    Leonor Munoz Alcivar, Yashwant Pathak, Pages: 35–55, 2012

    Published Online : 23 APR 2012, DOI: 10.1002/9781118229019.ch3

  8. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies

    Journal of Mass Spectrometry

    Volume 50, Issue 2, February 2015, Pages: 285–297, Alain Beck, François Debaene, Hélène Diemer, Elsa Wagner-Rousset, Olivier Colas, Alain Van Dorsselaer and Sarah Cianférani

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jms.3554

  9. Imaging EGFR and HER2 by PET and SPECT: A Review

    Medicinal Research Reviews

    Volume 34, Issue 3, May 2014, Pages: 596–643, Emily B. Corcoran and Robert N. Hanson

    Version of Record online : 29 AUG 2013, DOI: 10.1002/med.21299

  10. You have free access to this content
    Abstracts of ICI 2016 International Congress of Immunology, 21–26 August 2016, Melbourne, Australia

    European Journal of Immunology

    Volume 46, Issue S1, August 2016, Pages: 1–1274,

    Version of Record online : 19 AUG 2016, DOI: 10.1002/eji.201670200

  11. You have full text access to this OnlineOpen article
    [64Cu]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 58, Issue 6, 30 May 2015, Pages: 227–233, Christina Schjoeth-Eskesen, Carsten Haagen Nielsen, Søren Heissel, Peter Højrup, Paul Robert Hansen, Nic Gillings and Andreas Kjaer

    Version of Record online : 24 APR 2015, DOI: 10.1002/jlcr.3287

  12. You have free access to this content
    Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy

    Cytometry Part A

    Volume 67A, Issue 2, October 2005, Pages: 161–171, Elza Friedländer, Donna J. Arndt-Jovin, Péter Nagy, Thomas M. Jovin, János Szöllősi and György Vereb

    Version of Record online : 14 SEP 2005, DOI: 10.1002/cyto.a.20173

  13. Design and evaluation of radiolabeled tracers for tumor imaging

    Biotechnology and Applied Biochemistry

    Volume 60, Issue 4, July/August 2013, Pages: 365–383, Helena Wållberg and Stefan Ståhl

    Version of Record online : 22 AUG 2013, DOI: 10.1002/bab.1111

  14. Empowered Antibodies for Cancer Therapy

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Stephen C. Alley, Simone Jeger, Robert P. Lyon, Django Sussman, Peter D. Senter, Pages: 289–323, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch10

  15. Antibody–drug conjugates: an emerging modality for the treatment of cancer

    Annals of the New York Academy of Sciences

    Volume 1321, Issue 1, August 2014, Pages: 41–54, Mauricio Leal, Puja Sapra, Sara A. Hurvitz, Peter Senter, Alan Wahl, Melissa Schutten, Dhaval K. Shah, Nahor Haddish-Berhane and Omar Kabbarah

    Version of Record online : 14 AUG 2014, DOI: 10.1111/nyas.12499

  16. Strategies for Specific Drug Targeting to Tumour Cells

    Drug Targeting: Organ-Specific Strategies

    Jos G. W. Kosterink, Wijnand Helfrich, Lou F. M. H. de Leij, Pages: 199–231, 2001

    Published Online : 11 OCT 2001, DOI: 10.1002/352760006X.ch8

  17. You have free access to this content
    New clinical advances in immunotherapy for the treatment of solid tumours

    Immunology

    Volume 145, Issue 2, June 2015, Pages: 182–201, Valentina A. Zavala and Alexis M. Kalergis

    Version of Record online : 30 MAR 2015, DOI: 10.1111/imm.12459

  18. Antikörper – neue Krebsmedikamente. Gezielt wirksame Biomedizin

    Chemie in unserer Zeit

    Volume 43, Issue 5, Oktober 2009, Pages: 328–338, Max Hasmann, Christian Klein and Georg-Burkhard Kresse

    Version of Record online : 9 OCT 2009, DOI: 10.1002/ciuz.200900494

  19. You have free access to this content
    Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response

    International Journal of Cancer

    Volume 131, Issue 10, 15 November 2012, Pages: 2420–2432, Sucheta Kulkarni, Leya Saju, Carol Farver and Raymond Tubbs

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ijc.27510

  20. Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1382–1402, Jie Ling, Honghui Zhou, Qun Jiao and Hugh M. Davis

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009337134